Results 261 to 270 of about 1,837,011 (336)

Emerging Biomedical Engineering Therapies for Infected Diabetic Foot Ulcers: Toward Antibacterial Functionalization and Pathology‐Responsive Regulation

open access: yesSmall Science, Volume 6, Issue 1, January 2026.
Infected diabetic foot ulcer endangers patients with high amputation, disability, mortality risks, and heavy medical burdens. This review analyzes its pathogenic factors, the limitations of current treatments, the breakthroughs of responsive antimicrobial biomaterials, and the challenge of multifunctional biomaterial innovations for further developing ...
Yaqi Yao   +8 more
wiley   +1 more source

A Scoping Review to Map Health Outcomes in Inducible Laryngeal Obstruction

open access: yesInternational Journal of Language &Communication Disorders, Volume 61, Issue 1, January/February 2026.
ABSTRACT Background Inducible laryngeal obstruction (ILO) is defined as an inappropriate laryngeal closure causing difficulty in breathing. Outcome measures can be used in ILO to monitor changes in health status over time. A comprehensive review of existing measures is important to understand what the targets of treatment and management are and whether
S. F. Ludlow   +4 more
wiley   +1 more source

Destination categories, channel choice, and beer distribution laws

open access: yesAmerican Journal of Agricultural Economics, Volume 108, Issue 1, Page 143-175, January 2026.
Abstract Consumers tend to choose the type of store, or grocery channel, on the basis of “destination categories,” or categories that tend to be important attractors relative to others. Whether or not a category is truly important to generating incremental market share, however, is a difficult empirical question, because there has been little exogenous
Anna Malinovskaya   +2 more
wiley   +1 more source

Prospective case‐control cohort analysis of two‐day/two‐stage pelvic exenteration surgery: Safety, feasibility, acceptability and medium‐term outcomes

open access: yesColorectal Disease, Volume 28, Issue 1, January 2026.
Abstract Aim Pelvic exenteration (PE) is the only curative option for extensive pelvic cancers. Advances have facilitated increasingly complex resectional and reconstructive components, including per‐operative oncological adjuncts such as intraoperative radiotherapy.
Charles T. West   +8 more
wiley   +1 more source

A Multicenter Observational Study for the Establishment of Novel Severity Criteria Including Endoscopic Evaluation for Intestinal Behçet's Disease

open access: yesDigestive Endoscopy, Volume 38, Issue 1, January 2026.
The establishment of novel severity criteria for intestinal Behçet's disease. ABSTRACT Objective This study aimed to establish a novel severity classification for intestinal Behçet's disease (BD) (SCIBD) and validate its criteria across multiple institutions.
Toshiro Fukui   +20 more
wiley   +1 more source

Influence of Sleep and Wakefulness States and Physical Activity on Chronic Pain in Temporomandibular Disorders

open access: yesJournal of Oral Rehabilitation, Volume 53, Issue 1, Page 175-183, January 2026.
The present study suggested that jaw pain decreased when sleep satisfaction of the previous night was high, more physical activity on the previous day was associated with less jaw pain, and the jaw pain on the day of the study was more intense when the jaw pain on the previous day was severe.
Koichiro Uno   +4 more
wiley   +1 more source

Clinical Trial: Efficacy and Safety of Velusetrag in Chronic Intestinal Pseudo‐Obstruction: A Randomized, Phase 2, Placebo‐Controlled, Crossover, Multiple (n = 1), Proof‐of‐Concept Study

open access: yesNeurogastroenterology &Motility, Volume 38, Issue 1, January 2026.
This phase 2 proof‐of‐concept trial evaluated the efficacy and safety of velusetrag in patients with chronic intestinal pseudo‐obstruction. Velusetrag treatment was generally well tolerated and was associated with improved symptoms and a reduction in pseudo‐obstructive episodes versus placebo, although these differences did not reach statistical ...
Carolina Malagelada   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy